Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

FPS workshops - Containment & Micronization

Tuesday, July 31, 2018

FPS is pleased to announce the selected dates for two workshops on containment and micronization that will be held place in October and November in Fiorenzuola dArdaThe first o

HitGen Extends and Expands Research Collaboration and License Agreement With MSD To Build and Screen Novel DNA-Encoded Libraries

Tuesday, July 31, 2018

HitGen Ltd is pleased to announce that the company has extended and expanded its agreement with MSD known as Merck Co Inc Kenilworth NJ USA into a multiyear research collaboration and license agreement to build and screen novel DNAencoded libraries...

Advaxis Announces FDA Allowance of IND Application for ADXS-HOT Drug Candidate for Non-Small Cell Lung Cancer

Tuesday, July 31, 2018

Advaxis Inc a latestage biotechnology company focused on the discovery development and commercialization of immunotherapy products today announced that the US Food and Drug Administration FDA has allowed the Companys IND application for its ADXSHOT d...

Daiichi Sankyo Enters Worldwide Licensing Agreement with Glycotope for Gatipotuzumab Antibody Drug Conjugate

Monday, July 30, 2018

Daiichi Sankyo Company Limited hereafter Daiichi Sankyo and Glycotope GmbH hereafter Glycotope have entered into an exclusive worldwide licensing agreement to develop an antibody drug conjugate ADC by combining Daiichi Sankyos proprietary ADC technol...

Propanc Biopharma Enters National Phase for Two Key Patents

Friday, July 27, 2018

Propanc Biopharma Inc a clinical stage biopharmaceutical company focusing on development of new and proprietary treatments for cancer patients suffering from solid tumors such as pancreatic ovarian and colorectal cancers today announced that the Comp...

WuXi STA’s Jinshan Site Passes Fourth U.S. FDA Inspection

Thursday, July 26, 2018

STA Pharmaceutical Co Ltd a subsidiary of WuXi AppTec announces that its Active Pharmaceutical Ingredient API manufacturing facility at Jinshan Shanghai China has successfully passed its fourth inspection from the US Food and Drug Administration USFD...

Omeros’ OMS721 Receives European Orphan Drug Designation Positive Opinion for Treatment in Hematopoietic Stem Cell Transplantation

Thursday, July 26, 2018

Omeros Corporation announced today that the European Medicines Agencys EMAs Committee for Orphan Medicinal Products COMP issued a positive opinion recommending orphan drug designation of OMS for treatment in hematopoietic stem cell transplantation OM...

Convelo Therapeutics to Develop New Regenerative Medicines for Neurological Disease Characterized by Loss of Myelin

Thursday, July 26, 2018

Convelo Therapeutics Inc announced today that it has launched from stealth mode with a mission to discover and develop a new class of medicines that regenerate the protective myelin coating around nerve cells that is lost in a wide array of neurologi...

Oramed Granted Japanese Patent for GLP-1 Analog Capsule

Wednesday, July 25, 2018

Oramed Pharmaceuticals Inc wwworamedcom a clinicalstage pharmaceutical company focused on the development of oral drug delivery systems announced today that the Japanese Intellectual Property Office has publicized its intent to grant Oramed a patent...

Apellis Pharmaceuticals’ APL-2 Receives Fast Track Designation from FDA for the Treatment of Patients with Geographic Atrophy

Wednesday, July 25, 2018

Apellis Pharmaceuticals Inc a clinicalstage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system today announced that the US Food and Drug Administration...